Page 97 - Read Online
        P. 97
     Page 18 of 20          Nakamura et al. Mini-invasive Surg 2022;6:50  https://dx.doi.org/10.20517/2574-1225.2022.38
               21.      Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic
                   submucosal dissection for gastric neoplasms. Gastrointest Endosc 2013;78:476-83.  DOI  PubMed
               22.      Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric
                   neoplasms? Gastrointest Endosc 2012;75:719-27.  DOI  PubMed
               23.      Miyahara K, Iwakiri R, Shimoda R, et al. Perforation and postoperative bleeding of endoscopic submucosal dissection in gastric
                   tumors: analysis of 1190 lesions in low- and high-volume centers in Saga, Japan. Digestion 2012;86:273-80.  DOI  PubMed
               24.      Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal
                   dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 2012;27:907-12.  DOI  PubMed
               25.      Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum:
                   complication rates and long-term outcomes. Surg Endosc 2013;27:1000-8.  DOI  PubMed  PMC
               26.      Kim TS, Kim B, Min BH, et al. Outcomes of endoscopic submucosal dissection for intestinal-type adenocarcinoma with anastomosing
                   glands of the stomach. J Gastroenterol Hepatol 2020;35:50-5.  DOI  PubMed
               27.      Nam HS, Choi CW, Kim SJ, et al. Risk factors for delayed bleeding by onset time after endoscopic submucosal dissection for gastric
                   neoplasm. Sci Rep 2019;9:2674.  DOI  PubMed  PMC
               28.      Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from
                   ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol
                   2007;102:1610-6.  DOI  PubMed
               29.      Libânio D, Costa MN, Pimentel-Nunes P, Dinis-Ribeiro M. Risk factors for bleeding after gastric endoscopic submucosal dissection: a
                   systematic review and meta-analysis. Gastrointest Endosc 2016;84:572-86.  DOI  PubMed
               30.      Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer:
                   BEST-J score. Gut 2021;70:476-84.  DOI  PubMed  PMC
               31.      Toya Y, Endo M, Sugai K, et al. Protective effect of proton pump inhibitors and potassium competitive acid blockers against post-
                   gastric endoscopic submucosal dissection bleeding: a single-center, propensity score-matched analysis. Scand J Gastroenterol
                   2021;56:199-204.  DOI  PubMed
               32.      Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced
                   gastric ulcers: a prospective randomized phase II study. J Gastroenterol 2019;54:122-30.  DOI  PubMed
               33.      Kakushima N, Ono H, Takizawa K, et al. Incidence of delayed bleeding among patients continuing antithrombotics during gastric
                   endoscopic submucosal dissection. Intern Med 2019;58:2759-66.  DOI  PubMed  PMC
               34.      Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J
                   Gastroenterol 2021;56:640-50.  DOI  PubMed
               35.      Fujimoto K, Fujishiro M, Kato M, et al; Japan Gastroenterological Endoscopy Society. Guidelines for gastroenterological endoscopy
                   in patients undergoing antithrombotic treatment. Dig Endosc 2014;26:1-14.  DOI  PubMed
               36.      Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral
                   anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
                   Endoscopy 2016;48:385-402.  DOI  PubMed
               37.      Acosta RD, Abraham NS, Chandrasekhara V, et al; ASGE Standards of Practice Committee. The management of antithrombotic
                   agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016;83:3-16.  DOI  PubMed
               38.      Dong J, Wei K, Deng J, et al. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. Gastrointest
                   Endosc 2017;86:807-16.  DOI  PubMed
               39.      Jaruvongvanich V, Sempokuya T, Wijarnpreecha K, Ungprasert P. Continued versus interrupted aspirin use and bleeding risk after
                   endoscopic submucosal dissection of gastric neoplasms: a meta-analysis. Ann Gastroenterol 2018;31:344-9.  DOI  PubMed  PMC
               40.      Tomida H, Yoshio T, Igarashi K, et al; FIGHT-Japan Study Group. Influence of anticoagulants on the risk of delayed bleeding after
                   gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric Cancer 2021;24:179-89.  DOI  PubMed
               41.      Kato M, Uedo N, Hokimoto S, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment:
                   2017 appendix on anticoagulants including direct oral anticoagulants. Dig Endosc 2018;30:433-40.  DOI  PubMed
               42.      Igarashi K, Takizawa K, Kakushima N, et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic
                   submucosal dissection? Surg Endosc 2017;31:1746-53.  DOI  PubMed
               43.      Yoshio T, Nishida T, Kawai N, et al. Gastric ESD under heparin replacement at high-risk patients of thromboembolism is technically
                   feasible but has a high risk of delayed bleeding: Osaka university ESD study group. Gastroenterol Res Pract 2013;2013:365830.  DOI
                   PubMed  PMC
               44.      Furuhata T, Kaise M, Hoteya S, et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving
                   antithrombotic therapy. Gastric Cancer 2017;20:207-14.  DOI  PubMed
               45.      Yoshio T, Tomida H, Iwasaki R, et al. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic
                   submucosal dissection. Dig Endosc 2017;29:686-94.  DOI  PubMed
               46.      Gotoda T, Hori K, Iwamuro M, et al. Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic
                   submucosal dissection. Endosc Int Open 2017;5:E653-62.  DOI  PubMed  PMC
               47.      Sanomura Y, Oka S, Tanaka S, et al. Taking warfarin with heparin replacement and direct oral anticoagulant is a risk factor for
                   bleeding after endoscopic submucosal dissection for early gastric cancer. Digestion 2018;97:240-9.  DOI  PubMed
               48.      Shindo Y, Matsumoto S, Miyatani H, Yoshida Y, Mashima H. Risk factors for postoperative bleeding after gastric endoscopic
     	
